The present invention relates to inhibitors of aspartic proteinases, particularly, BACE. The present invention also relates to compositions thereof and methods therewith for inhibiting BACE activity in a mammal, and for treating Alzheimer's Disease and other BACE-mediated diseases.
[EN] IL4I1 INHIBITORS AND METHODS OF USE<br/>[FR] INHIBITEURS D'IL4I1 ET PROCÉDÉS D'UTILISATION
申请人:MERCK SHARP & DOHME
公开号:WO2021226003A1
公开(公告)日:2021-11-11
Described herein are compounds of Formula I or a pharmaceutically acceptable salt thereof. The compounds of Formula I act as IL4I1 inhibitors and can be useful in preventing, treating or acting as a remedial agent for IL4I1-related diseases.
series of 3-carbamoylpiperidines (nipecotamides) are designed, synthesized and tested for their inhibitory action against adenosine diphosphate (ADP)-induced aggregation of human platelets. A structure-activity analysis of the bis(nipecotamido)aralkane type showed that a substituent on the piperidine ring should preferably be an amide and that the electronegativity of the carbonyl oxygen and the orientation
Hyperbranched: A Universal Conjugated Polymer Platform
作者:Juan Tolosa、Chris Kub、Uwe H. F. Bunz
DOI:10.1002/anie.200900980
日期:2009.6.8
monomer containing two iodine and one alkyne group forms a hyperbranched conjugatedpolymer that is studded with iodine end groups (see picture: I purple). These iodine groups are a perfect handle for convenient, efficient, and high‐yielding post‐functionalization to access hyperbranched, fluorescent poly(phenyleneethynylene)s.
Potential organ- or tumor-imaging agents. 18. Radioiodinated diamines and bisquaternaries
作者:C. C. Huang、N. Korn、R. E. Counsell
DOI:10.1021/jm00190a018
日期:1979.4
The purpose of this research was to employ diamines and their quaternary derivatives as carrier molecules for gamma-emitting radiation. The diamine putrescine is widespread in nature and has been reported to selectively concentrate in the rat ventral prostate and pancreas. This study confirms the selective uptake of radioactivity in the rat ventral prostate, but not in the pancreas, following administration